

LONDON, Oct 23 (Reuters) - Pharmaceutical firm Shire said it was still pursuing its attempt to buy U.S. company Baxalta as it posted a 11 percent ris...


(ShareCast News) - Drugmaker Shire will report its third quarter interims on Friday and analysts are raising doubts on the proposed takeover of US bio...


(Fixes spelling of "Tracleer" in eighth paragraph) * Biggest European biotech raises earnings forecast * Could afford acquisitions above $2.5 billion ...


(ShareCast News) - The top flight index underperformed as commodity markets weakened on the back of soft Chinese fixed asset investment and industrial...


* FTSE 100 down 0.4 pct, mining shares top losers * Shire volatile after declined drug approval * Barclays rises on media report (Updates with closi...


* FTSE 100 down 0.2 pct, mining shares top losers * Shire falls on declined drug approval * Barclays rises on media report (Adds detail) By Kit Rees...